Bio-sight Capital
VC Fund
Ibaraki, Japan
Bio-sight Capital is a private investment firm focused on lab business and investment business.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Bio-sight Capital invests in
Stages Bio-sight Capital invests in
Countries Bio-sight Capital invests in
Investment Focus
Industry
- Biotechnology 2 (25%)
- Drones 1 (13%)
- Medical 1 (13%)
- mHealth 1 (13%)
- Biopharma 1 (13%)
Stage
- Funding Round 5 (63%)
- Series A 1 (13%)
- Series B 1 (13%)
Country
- Japan 6 (75%)
- United States 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Scohia Pharma
|
Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic. | $442.5M / May 28, 2026 | |
DeepForest Technologies
|
DeepForest Technologies is an IT firm that offers drone photography, forest information analysis, DF Scanner, and data processing services. | $1.3M / Series A / Jun 18, 2024 | |
FunPep
|
FunPep is an Industry-university collaboration bioventure company. | $212.6M / Aug 14, 2020 | |
JTEC CORPORATION Japan
|
JTech Corporation designs, produces, and sells X-ray mirrors for synchrotron radiation facilities. It also offers products for automated cell culture systems, montel mirrors, spheroidal mirrors, rotating walter miller, deformable mirrors, multi channel mirrors, concentrators, and alteration of mirror shape. | $21M / Dec 18, 2015 | |
Gene Techno Science
|
Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.The company develops drugs for the treatment of immunological, cardiovascular, ophthalmic, infectious, and renal diseases as well as oncology drugs. It also offers Filgrastim for the treatment of cancer.Gene Techno Sciencewas founded in 2001 and is headquartered in Sapporo, Japan. | $70.9M / Jun 11, 2008 | |
B-Bridge International
|
B-Bridge International -- founded in 2000 and based in Santa Clara, California with branches in Japan -- acts as an incubator to connect the two business ecosystem to increase Japan's presence in the world, by educating companies and entrepreneurs of both cultures. | $4.2M / Mar 29, 2005 | |
|
FunPep
|
FunPep is an Industry-university collaboration bioventure company. | ||
LQUOM
|
QWAVE offers cryptography communication technology. | Series B |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Bio-sight Capital invest in?
Bio-sight Capital invests primarily in Biotechnology, Drones and Medical startups, most often at Funding Round and Series A stage. Most of the 8 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Bio-sight Capital last invest?
The most recent investment recorded for Bio-sight Capital closed in Jun 2024. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
